“If we understand the effects of this GNAS mutation, we can develop treatments or nominate certain patients for surgical intervention, which could prevent the poorest outcomes from ever manifesting,” said Patra, University of Cincinnati Cancer Center researcher and assistant professor in the UC College of Medicine’s Department of Cancer Biology.
Patra previously developed one of the first animal models that replicated GNAS mutant pancreatic cancer. Using the model, his team learned that when the GNAS mutation is present in pancreatic cancer, it plays a role in tumor initiation, progression and maintenance. Specifically, GNAS alters the metabolism of cancer cells, creating a metabolic pathway that is unique in GNAS-mutated pancreatic cancer compared to other pancreatic cancer subtypes.
Advertisement
“This NCI award will allow us to recruit talented graduate students and postdoctoral fellows in the lab to study how GNAS changes gene expression and alters mitochondrial structure and function that helps the tumors to grow,” Patra said.
Collaborative Environment and Inspiration for Pancreatic Cancer Research
Patra said he is very excited about the future of the project and credits the environment at the Cancer Center, UC College of Medicine and research affinity groups as keys to his success.
“For example, my Metabolism, Signaling and Therapeutics in Cancer affinity group, which we initiated in conjunction with the Plas, Czyzyk-Krzeska and Cunningham laboratories, provides a forum between collaborators to discuss research progress and refine projects such as this one that ultimately become funded grants and publications,” Patra said. “I am also thankful to many other colleagues including Drs. Jarek Meller, Ken Greis, JJ Diao, Syed Ahmad and Davendra Sohal, whose interactions are vital to the feasibility of this research project.”
As he continues his research, Patra said he is inspired both because of his scientific curiosity of a disease that is not fully understood and through his interactions with patients and their families looking for advancements in treatment options.
“The patients reach out to me, and that is really very motivating and shows us that we have a lot of work to do,” he said.
Source: Eurekalert
Source link
#Mutations #Pancreatic #Cancer #Grow
